PDL BioPharma Inc (NASDAQ:PDLI)

7.07
Delayed Data
As of Mar 26
 +0.07 / +1.00%
Today’s Change
6.52
Today|||52-Week Range
10.26
-8.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line199.4M211.7M264.5M322.2M
 
 
 
 
 
Depreciation1.4M946.0K5.6M--
 
 
 
 
Total Other Cash Flow11.0M14.4M13.8M-38.6M
 
 
 
 
 
Funds From Operations243.0M238.3M282.9M283.6M
 
 
 
 
 
Funds From/For Other Operating Expenses73.2M28.1M12.0M-8.6M
 
 
 
 
 
Net Cash Flow - Operating Activities169.8M210.2M270.9M292.3M
 
 
 
 
 
 
InvestingIncrease In Investments-74.7M-125.2M-9.9M--
 
 
 
 
Decrease In Investments50.7M50.8M43.8M--
 
 
 
 
Capital Expenditures0.00-51.0K-2.0K--
 
 
 
Other Investing - Uses0.000.00-148.7M--
 
 
Other Investing - Sources0.005.0M58.1M--
 
 
 
Net Cash Flow Investing-24.0M-69.4M-298.0M--
 
 
 
 
 
FinancingShort Term Borrowings0.00-93.4M74.2M--
 
 
 
Long Term Borrowings149.7M-845.0K0.00--
 
 
 
Long Term Debt Reduction-244.8M0.000.00--
 
 
Net Proceeds Stock Sale10.9M0.000.00--
 
 
Common Preferred Redeemed-20.8M0.000.00--
 
 
Common Dividends-83.8M-83.9M-84.0M--
 
 
 
 
Cash Dividends Paid - Total-83.8M-83.9M-84.0M--
 
 
 
 
Other Sources - Financing0.0027.0K22.0K--
 
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing-188.8M-178.1M-9.8M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-43.0M-37.3M-36.9M292.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account